Clinical Trial Update: Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for bencycloquidium bromide nasal spray in moderate-severe persistent allergic rhinitis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Bencycloquidium bromide nasal spray (bencycloquidium bromide)

Snippet

Sponsor: Yingu Pharmaceutical Co., Ltd | Conditions: Allergic Rhinitis | Phase 4 | Status: UNKNOWN